Cell Therapeutics (CTIC)

Add a New Bears Reason Company: Cell Therapeutics (CTIC) Current price: Headline: (100 character max) Analysis: Cancel 71% agree 7 votes   Waiting for FDA Created when NASDAQ:CTIC was $1.14 | Edit | History This stock will continue to fall until Mar/April 2010. The FDA has set April 23, 2010 as their review date. I would wait until Jan/Feb. 2010 time frame, then buy. If FDA gives a positive review, price will climb, but until then I don't see any real reason to purchase this stock. (100 character max) Cancel 60% agree 5 votes   ctic fluk Created when NASDAQ:CTIC was $1.09 | Edit | History toxicity,fda denials,baseline benifits,selling of rights and assets,debts, all point to bubble burst to 0.5 again (100 character max) Cancel 0% agree 0 votes   Lawsuits Created when NASDAQ:CTIC was $1.03 | Edit | History With all these lawsuits and investigations that popped up, I think that the price will fall as the business practices of the company are made public. (100 character max) Cancel 50% agree 2 votes   ctic fails endpoint Created when NASDAQ:CTIC was $1.11 | Edit | History this co has little chance of fha approval due to toxicity (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.